The Promise of Molecularly Targeted and Immunotherapy for Advanced Melanoma von Margolin, Kim

Volltext

Cytokines in cancer immunotherapy von Lee, Sylvia, Margolin, Kim

Volltext

Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial von Motzer, Robert J, Rini, Brian I, McDermott, David F, Redman, Bruce G, Kuzel, Timothy M, Harrison, Michael R, Vaishampayan, Ulka N, Drabkin, Harry A, George, Saby, Logan, Theodore F, Margolin, Kim A, Plimack, Elizabeth R, Lambert, Alexandre M, Waxman, Ian M, Hammers, Hans J

Volltext

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma von Schadendorf, Dirk, Hodi, F Stephen, Robert, Caroline, Weber, Jeffrey S, Margolin, Kim, Hamid, Omid, Patt, Debra, Chen, Tai-Tsang, Berman, David M, Wolchok, Jedd D

Volltext

Ipilimumab in a Phase II trial of melanoma patients with brain metastases von Margolin, Kim

Volltext

Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre... von Tawbi, Hussein A, Forsyth, Peter A, Hodi, F Stephen, Algazi, Alain P, Hamid, Omid, Lao, Christopher D, Moschos, Stergios J, Atkins, Michael B, Lewis, Karl, Postow, Michael A, Thomas, Reena P, Glaspy, John, Jang, Sekwon, Khushalani, Nikhil I, Pavlick, Anna C, Ernstoff, Marc S, Reardon, David A, Kudchadkar, Ragini, Tarhini, Ahmad, Chung, Caroline, Ritchings, Corey, Durani, Piyush, Askelson, Margarita, Puzanov, Igor, Margolin, Kim A

Volltext

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma von Patel, Sapna P., Othus, Megan, Chen, Yuanbin, Wright, G. Paul, Yost, Kathleen J., Hyngstrom, John R., Hu-Lieskovan, Siwen, Lao, Christopher D., Fecher, Leslie A., Truong, Thach-Giao, Eisenstein, Jennifer L., Chandra, Sunandana, Sosman, Jeffrey A., Kendra, Kari L., Wu, Richard C., Devoe, Craig E., Deutsch, Gary B., Hegde, Aparna, Khalil, Maya, Mangla, Ankit, Reese, Amy M., Ross, Merrick I., Poklepovic, Andrew S., Phan, Giao Q., Onitilo, Adedayo A., Yasar, Demet G., Powers, Benjamin C., Doolittle, Gary C., In, Gino K., Kokot, Niels, Gibney, Geoffrey T., Atkins, Michael B., Shaheen, Montaser, Warneke, James A., Ikeguchi, Alexandra, Najera, Jose E., Chmielowski, Bartosz, Crompton, Joseph G., Floyd, Justin D., Hsueh, Eddy, Margolin, Kim A., Chow, Warren A., Grossmann, Kenneth F., Dietrich, Eliana, Prieto, Victor G., Lowe, Michael C., Buchbinder, Elizabeth I., Kirkwood, John M., Korde, Larissa, Moon, James, Sharon, Elad, Sondak, Vernon K., Ribas, Antoni

Volltext

What is new on the horizon in melanoma brain metastasis? von Margolin, Kim

Volltext

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain von Tawbi, Hussein A, Forsyth, Peter A, Algazi, Alain, Hamid, Omid, Hodi, F. Stephen, Moschos, Stergios J, Khushalani, Nikhil I, Lewis, Karl, Lao, Christopher D, Postow, Michael A, Atkins, Michael B, Ernstoff, Marc S, Reardon, David A, Puzanov, Igor, Kudchadkar, Ragini R, Thomas, Reena P, Tarhini, Ahmad, Pavlick, Anna C, Jiang, Joel, Avila, Alexandre, Demelo, Sheena, Margolin, Kim

Volltext

After a treatment breakthrough—progress, plateaus, and raising the bar von Margolin, Kim A.

Volltext

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial von Ribas, Antoni, Prof, Puzanov, Igor, MD, Dummer, Reinhard, Prof, Schadendorf, Dirk, Prof, Hamid, Omid, MD, Robert, Caroline, Prof, Hodi, F Stephen, MD, Schachter, Jacob, Prof, Pavlick, Anna C, MD, Lewis, Karl D, MD, Cranmer, Lee D, MD, Blank, Christian U, MD, O'Day, Steven J, MD, Ascierto, Paolo A, Prof, Salama, April K S, MD, Margolin, Kim A, Prof, Loquai, Carmen, MD, Eigentler, Thomas K, MD, Gangadhar, Tara C, MD, Carlino, Matteo S, MBBS, Agarwala, Sanjiv S, Prof, Moschos, Stergios J, MD, Sosman, Jeffrey A, Prof, Goldinger, Simone M, MD, Shapira-Frommer, Ronnie, MD, Gonzalez, Rene, Prof, Kirkwood, John M, Prof, Wolchok, Jedd D, Prof, Eggermont, Alexander, Prof, Li, Xiaoyun Nicole, PhD, Zhou, Wei, PhD, Zernhelt, Adriane M, BS, Lis, Joy, BSN, Ebbinghaus, Scot, MD, Kang, S Peter, MD, Daud, Adil, Prof

Volltext

Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma von Hamid, Omid, Puzanov, Igor, Dummer, Reinhard, Schachter, Jacob, Daud, Adil, Schadendorf, Dirk, Blank, Christian, Cranmer, Lee D., Robert, Caroline, Pavlick, Anna C., Gonzalez, Rene, Hodi, F. Stephen, Ascierto, Paolo A., Salama, April K.S., Margolin, Kim A., Gangadhar, Tara C., Wei, Ziwen, Ebbinghaus, Scot, Ibrahim, Nageatte, Ribas, Antoni

Volltext

Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512 von Bhatia, Shailender, Moon, James, Margolin, Kim A, Weber, Jeffrey S, Lao, Christopher D, Othus, Megan, Aparicio, Ana M, Ribas, Antoni, Sondak, Vernon K

Volltext

Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression von Egelston, Colt A., Avalos, Christian, Tu, Travis Y., Simons, Diana L., Jimenez, Grecia, Jung, Jae Y., Melstrom, Laleh, Margolin, Kim, Yim, John H., Kruper, Laura, Mortimer, Joanne, Lee, Peter P.

Volltext

Validation and Implementation of Targeted Capture and Sequencing for the Detection of Actionable Mutation, Copy Number Variation, and Gene Rearrangement in Clinical Cancer Specimen... von Pritchard, Colin C, Salipante, Stephen J, Koehler, Karen, Smith, Christina, Scroggins, Sheena, Wood, Brent, Wu, David, Lee, Ming K, Dintzis, Suzanne, Adey, Andrew, Liu, Yajuan, Eaton, Keith D, Martins, Renato, Stricker, Kari, Margolin, Kim A, Hoffman, Noah, Churpek, Jane E, Tait, Jonathan F, King, Mary-Claire, Walsh, Tom

Volltext

Nivolumab plus ipilimumab in melanoma brain metastases – Authors' reply von Tawbi, Hussein A, Eroglu, Zeynep, Anders, Carey K, Margolin, Kim A

Volltext

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial von Margolin, Kim, Prof, Ernstoff, Marc S, MD, Hamid, Omid, MD, Lawrence, Donald, MD, McDermott, David, MD, Puzanov, Igor, MD, Wolchok, Jedd D, MD, Clark, Joseph I, Prof, Sznol, Mario, MD, Logan, Theodore F, MD, Richards, Jon, MD, Michener, Tracy, PharmD, Balogh, Agnes, MS, Heller, Kevin N, MD, Hodi, F Stephen, MD

Volltext

Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient von Chapuis, Aude G, Lee, Sylvia M, Thompson, John A, Roberts, Ilana M, Margolin, Kim A, Bhatia, Shailender, Sloan, Heather L, Lai, Ivy, Wagener, Felecia, Shibuya, Kendall, Cao, Jianhong, Wolchok, Jedd D, Greenberg, Philip D, Yee, Cassian

Volltext

Phase 2 study of RO4929097, a gamma‐secretase inhibitor, in metastatic melanoma: SWOG 0933 von Lee, Sylvia M., Moon, James, Redman, Bruce G., Chidiac, Tarek, Flaherty, Lawrence E., Zha, Yuanyuan, Othus, Megan, Ribas, Antoni, Sondak, Vernon K., Gajewski, Thomas F., Margolin, Kim A.

Volltext

Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype von Chapuis, Aude G, Thompson, John A, Margolin, Kim A, Rodmyre, Rebecca, Lai, Ivy P, Dowdy, Kaye, Farrar, Erik A, Bhatia, Shailender, Sabath, Daniel E, Cao, Jianhong, Li, Yongqing, Yee, Cassian

Volltext